2018
DOI: 10.1002/ajh.25160
|View full text |Cite
|
Sign up to set email alerts
|

The effect of azacitidine therapy on the M protein of MDS patients with concomitant MGUS

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
0
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(2 citation statements)
references
References 6 publications
0
0
0
Order By: Relevance
“…MGUS is a precancerous condition characterized by an asymptomatic increase in plasma cells. MGUS is observed in 3.5% of individuals over 50 years of age [8,9]. Various pathophysiological conditions such as kidney failure, anemia, hypercalcemia, thrombocytopenia, lytic bone lesions, and bone pain occur because of the extra protein and monoclonal antibodies produced as a result of conversion from MGUS to MM, which complicates the patient's life [10].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…MGUS is a precancerous condition characterized by an asymptomatic increase in plasma cells. MGUS is observed in 3.5% of individuals over 50 years of age [8,9]. Various pathophysiological conditions such as kidney failure, anemia, hypercalcemia, thrombocytopenia, lytic bone lesions, and bone pain occur because of the extra protein and monoclonal antibodies produced as a result of conversion from MGUS to MM, which complicates the patient's life [10].…”
Section: Discussionmentioning
confidence: 99%
“…The importance of TP53 in tumor suppression in malignancies is well established. TP53 dysregulation is involved in the pathogenesis of many malignancies [8]. On the other hand, the importance of other genes that regulate the cellular response to DNA damage and stress by being in the same pathway as p53 in MGUS MM transformation is not clear enough [3,5].…”
Section: Discussionmentioning
confidence: 99%